Citations

Showing 10 of 108119 citations.

Management of Clostridioides difficile colitis: insights for the gastroenterologist
Saha, Srishti , Khanna, Sahil

Mayo Clinic

Therapeutic Advances in Gastroenterology | May 7, 2019 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/1756284819847651 | PMID 31105766 Get It

Clostridioides difficile infection (CDI) is a common cause of diarrhea in both inpatient and outpatient settings. The last few years have seen major changes in the treatment spectrum of CDI, most notably, recommendations against using metronidazole for initial CDI, the addition of fidaxomicin and bezlotoxumab, and emergence of microbial replacement therapies. Several other therapies are undergoing clinical trials. This narrative review focuses on the treatment of CDI with a summary of literature on the newer modalities and the treatment guidelines issued by Infectious Diseases Society of America and European Society of Clinical Microbiology and Infectious Diseases.
Portopulmonary Hypertension: Understanding Pulmonary Hypertension in the Setting of Liver Disease
Krowka, Michael J.

Mayo Clinic

Advances in Pulmonary Hypertension | May 7, 2019 | Volume: 3 | Issue: 2 | Pages: 4-8

10.21693/1933-088x-3.2.4 Get It

Diagnostic Dilemmas: Diastolic Heart Failure Causing Pulmonary Hypertension and Pulmonary Hypertension Causing Diastolic Dysfunction
Shapiro, Brian P. , McGoon, Michael D., Redfield, Margaret M. , Nishimura, Rick A.

Mayo Clinic

Advances in Pulmonary Hypertension | May 7, 2019 | Volume: 5 | Issue: 1 | Pages: 13-20

10.21693/1933-088x-5.1.13 Get It

The Vasoreactive Patient: Diagnosis, Treatment, and Follow-up
Murali, Srinivas, Burger, Charles D.

Mayo Clinic

Advances in Pulmonary Hypertension | May 7, 2019 | Volume: 6 | Issue: 4 | Pages: 176-179

10.21693/1933-088x-6.4.176 Get It

Ask the Expert
Krowka, Michael J.

Mayo Clinic

Advances in Pulmonary Hypertension | May 7, 2019 | Volume: 8 | Issue: 4 | Pages: 197-236

10.21693/1933-088x-8.4.197 Get It

What Can be Learned in 6 Minutes? 6-Minute Walk Test Primer and Role in Pulmonary Arterial Hypertension
Zeiger, Tonya K., Burger, Charles D.

Mayo Clinic

Advances in Pulmonary Hypertension | May 7, 2019 | Volume: 9 | Issue: 2 | Pages: 107-111

10.21693/1933-088x-9.2.107 Get It

The 6-minute walk test is an easy to perform and practical test that has been used in the assessment of patients with a variety of cardiopulmonary diseases including pulmonary arterial hypertension. The correlation with maximal cardiac output renders the test an indirect measure of right ventricular function in patients with significant pulmonary arterial hypertension. The test has been employed in the majority of studies evaluating the efficacy of pulmonary arterial vasodilators. In addition, the distance walked has been demonstrated to correlate with prognosis. An understanding of the 6-minute walk test indications, logistics, limitations, and interpretation is important to the clinician utilizing this test to evaluate patients with pulmonary arterial hypertension.
The Structure of Pulmonary Hypertension Health Care Delivery: Translating Ethical Considerations into Practice
McGoon, Michael D.

Mayo Clinic

Advances in Pulmonary Hypertension | May 7, 2019 | Volume: 9 | Issue: 4 | Pages: 204-207

10.21693/1933-088x-9.4.204 Get It

The ethical imperative to provide optimal care to patients applies not only to individual caregivers, but also to the medical community as a whole. Best care frequently requires a team approach. This is the obvious basis for the common practice of referring a patient from one physician to another for all or part of the patient's management. The incremental benefit may occur by providing specialized knowledge to the medical issue at hand; by contributing a broad second perspective to an incompletely defined clinical problem; by applying particular technical skills; or by facilitating access to an infrastructure of management not otherwise available. Other less obvious advantages may result from referrals, such as reducing for the referring caregiver the intensity of labor involved in managing a complex patient and enhancing the breadth and depth of experience of the referred-to caregiver. This in turn may allow economies of scale to improve efficiency of clinical care, promote knowledge acquisition by observation of multiple cases, and facilitate opportunities for formal clinical research. Many of these issues are particularly relevant for diseases that occur relatively infrequently, especially if management is capable of influencing outcome. Pulmonary arterial hypertension is an example of this category of disease. Are there principles that can be articulated to guide collaboration among caregivers to promote the best possible outcome in the most patients?
Paradox of Low-Gradient Aortic Stenosis
Reddy, Yogesh N.V. , Nishimura, Rick , Nishimura, Rick A.

Mayo Clinic

Circulation | May 7, 2019 | Volume: 139 | Issue: 19 | Pages: 2195-2197

10.1161/circulationaha.118.038252 | PMID 31059323 Get It

Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome
Dziadzko, Volha, Dziadzko, Mikhail , Medina‐Inojosa, José R. , Benfari, Giovanni , Maalouf, Joseph F., Thapa, Prabin , Enriquez‐Sarano, Maurice , Enriquez-Sarano, Maurice , Medina-Inojosa, José R , Benfari, Giovanni , Michelena, Héctor I. , Crestanello, Juan A.

Mayo Clinic

European Heart Journal | May 7, 2019 | Volume: 40 | Issue: 27 | Pages: 2194-2202

10.1093/eurheartj/ehz314 | PMID 31121021 Get It

Abstract Aims To define the hitherto unknown aetiology/mechanism distributions of mitral regurgitation (MR) in the community and the linked clinical characteristics/outcomes. Methods and results We identified all isolated, moderate/severe MR diagnosed in our community (Olmsted County, MN, USA) between 2000 and 2010 and classified MR aetiology/mechanisms. Eligible patients (n = 727) were 73 ± 18 years, 51% females, with ejection fraction (EF) 49 ± 17%. MR was functional (FMR) in 65%, organic (OMR) in 32% and 2% mixed. Functional MR was linked to left ventricular remodelling (FMR-v) 38% and isolated atrial dilatation (FMR-a) 27%. At diagnosis FMR-v vs. FMR-a, vs. OMR displayed profound differences (all P < 0.0001) in age (73 ± 14, 80 ± 10, 68 ± 21years), male-sex (59, 33, 51%), atrial-fibrillation (28, 54, 13%), EF (33 ± 14, 57 ± 11, 61 ± 10%), and regurgitant-volume (38 ± 13, 37 ± 11, 51 ± 24 mL/beat). Dominant MR mechanism was Type I (normal valve-movement) 38%, Type II (excessive valve-movement) 25%, Type IIIa (diastolic movement-restriction) 3%, and Type IIIb (systolic movement-restriction) 34%. Outcomes were mediocre with excess-mortality vs. general-population in FMR-v [risk ratio 3.45 (2.98–3.99), P < 0.0001] but also FMR-a [risk ratio 1.88 (1.52–2.25), P < 0.0001] and OMR [risk ratio 1.83 (1.50–2.22), P < 0.0001]. Heart failure was frequent, particularly in FMR-v (5-year 83 ± 3% vs. 59 ± 4% FMR-a, 40 ± 3% OMR, P < 0.0001). Mitral surgery during patients’ lifetime was performed in 4% of FMR-v, 3% of FMR-a, and 37% of OMR. Conclusion Moderate/severe isolated MR in the community displays considerable aetiology/mechanism heterogeneity. Functional MR dominates, mostly FMR-v but FMR-a is frequent and degenerative MR dominates OMR. Outcomes are mediocre with excess-mortality particularly with FMR-v but FMR-a, despite normal EF incurs notable excess-mortality and frequent heart failure. Pervasive undertreatment warrants clinical trials of therapies tailored to specific MR cause/mechanisms.
Use of a simulation-based advanced resuscitation training curriculum: Impact on cardiopulmonary resuscitation quality and patient outcomes
Young, Amanda , Simon, Leslie V. , Lowman, Philip, McKenna, Ryan , Thomas, Colleen S. , Cochuyt, Jordan J., Vadeboncoeur, Tyler F. , Young, Amanda K , Maniaci, Michael J. , Lowman, Philip E, McKenna, Ryan T

Mayo Clinic

Journal of the Intensive Care Society | May 7, 2019 | Volume: 21 | Issue: 1 | Pages: 57-63

10.1177/1751143719838209 | PMID 32284719 Get It

Background Despite a continued focus on improved cardiopulmonary resuscitation quality, survival remains low from in-hospital cardiac arrest. Advanced Resuscitation Training has been shown to improve survival to hospital discharge and survival with good neurological outcome following in-hospital cardiac arrest at its home institution. We sought to determine if Advanced Resuscitation Training implementation would improve patient outcomes and cardiopulmonary resuscitation quality at our institution. Methods This was a prospective, before–after study of adult in-hospital cardiac arrest victims who had cardiopulmonary resuscitation performed. During phase 1, standard institution cardiopulmonary resuscitation training was provided. During phase 2, providers received the same quantity of training, but with emphasis on Advanced Resuscitation Training principles. Primary outcomes were return of spontaneous circulation, survival to hospital discharge, and neurologically favorable survival. Secondary outcomes were cardiopulmonary resuscitation quality parameters. Results A total of 156 adult in-hospital cardiac arrests occurred during the study period. Rates of return of spontaneous circulation improved from 58.1 to 86.3% with an adjusted odds ratios of 5.31 (95% CI: 2.23–14.35, P < 0.001). Survival to discharge increased from 26.7 to 41.2%, adjusted odds ratios 2.17 (95% CI: 1.02–4.67, P < 0.05). Survival with a good neurological outcome increased from 24.8 to 35.3%, but was not statistically significant. Target chest compression rate increased from 30.4% of patients in P1 to 65.6% in P2, adjusted odds ratios 4.27 (95% CI: 1.72–11.12, P = 0.002), and target depth increased from 23.2% in P1 to 46.9% in P2, adjusted odds ratios 2.92 (95% CI: 1.16–7.54, P = 0.024). Conclusions After Advanced Resuscitation Training implementation, there were significant improvements in cardiopulmonary resuscitation quality and rates of return of spontaneous circulation and survival to discharge.